The Optilume BPH Catheter System for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia
- PMID: 38983480
- PMCID: PMC11228686
- DOI: 10.21037/tau-23-673
The Optilume BPH Catheter System for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia
Keywords: Benign prostatic hyperplasia (BPH); lower urinary tract symptoms (LUTSs); minimal invasive surgical treatments.
Conflict of interest statement
Conflicts of Interest: Both authors have completed the ICMJE uniform disclosure form (available at https://tau.amegroups.com/article/view/10.21037/tau-23-673/coif). S.S. is funded and supported by the Augusta University Startup Funds. The other author has no conflicts of interest to declare.
Comment on
-
The PINNACLE Study: A Double-blind, Randomized, Sham-controlled Study Evaluating the Optilume BPH Catheter System for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia.J Urol. 2023 Sep;210(3):500-509. doi: 10.1097/JU.0000000000003568. Epub 2023 Aug 9. J Urol. 2023. PMID: 37555604 Clinical Trial.
References
-
- Kaplan SA, Moss J, Freedman S, et al. The PINNACLE Study: A Double-blind, Randomized, Sham-controlled Study Evaluating the Optilume BPH Catheter System for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia. J Urol 2023;210:500-9. 10.1097/JU.0000000000003568 - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources